melphalan and Mandibular-Neoplasms

melphalan has been researched along with Mandibular-Neoplasms* in 9 studies

Other Studies

9 other study(ies) available for melphalan and Mandibular-Neoplasms

ArticleYear
Early clinical diagnosis of solitary plasmacytoma of the jaws: a case report with a six year follow-up.
    International journal of oral and maxillofacial surgery, 2001, Volume: 30, Issue:6

    The authors reported a case of a solitary mandibular plasmacytoma in a 53-year-old male Caucasian patient. The histological examination of the specimen was positive for a plasmacytoma with anaplastic appearance. Since the patient refused a demolitive surgical treatment, he was treated with a local radiation therapy of 4000 rads over a 20-day period and polychemotherapy with cyclophosphamide, prednisone and melphalan. Six years after starting radiation treatment the patient is free of recurrent primary disease and not affected by multiple localization. In conclusion, the solitary bone plasmacytoma represents an initial stage of the multiple myeloma rather than a distinct clinical pathology. Unfortunately, the diagnosis of the plasmacytoma is only rarely carried out in the early phases of the disease. The importance of the identification of the initial stage without a clear M component, as in the reported case, is self-evident, since the prognosis is related to the mass of plasmacytoma cells that are present at the time of the diagnosis. The purpose of this study is to report an extremely rare case of solitary bone plasmacytoma with a mandibular localization treated with radio- and polychemotherapy.

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Follow-Up Studies; Humans; Male; Mandibular Neoplasms; Melphalan; Middle Aged; Plasmacytoma; Prednisone; Prognosis; Radiotherapy Dosage; Remission Induction

2001
Mandibular mass as the presenting manifestation of IgM myeloma in a 22-year-old man.
    Annals of hematology, 1999, Volume: 78, Issue:2

    We report here the youngest known IgM myeloma patient to have presented with a mandibular mass. A 22-year-old Chinese man sought medical attention due to a mass over his right mandible that had been growing progressively for 6 months. A solitary osteolytic lesion in the right mandible was identified radiologically. Incisional biopsy revealed the presence of plasma cells of monoclonal origin, as evidenced by the exclusively positive staining of the kappa light chain. The diagnosis of multiple myeloma with mandibular involvement was confirmed by bone marrow examination. Further tests, including immunoglobulin electrophoresis and assay of the serum levels of kappa and lambda light chains, demonstrated that his myeloma was of the IgM, kappa subtype. The patient achieved a nonsustained partial response to six courses of melphalan and prednisolone therapy and palliative radiotherapy.

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Immunoglobulin kappa-Chains; Immunoglobulin M; Male; Mandibular Neoplasms; Melphalan; Multiple Myeloma; Myeloma Proteins; Osteolysis; Palliative Care; Prednisolone

1999
Paresthesia of the mandibular division, trigeminal nerve.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1993, Volume: 51, Issue:5

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Female; Humans; Mandibular Neoplasms; Mandibular Nerve; Melphalan; Middle Aged; Multiple Myeloma; Paresthesia; Prednisone; Radiography; Sex Factors

1993
Osteogenic sarcoma (osteosarcoma): results of therapy.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1975, Volume: 123, Issue:3

    Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Femoral Neoplasms; Follow-Up Studies; Frontal Bone; Humans; Humerus; Ilium; Male; Mandibular Neoplasms; Maxillary Neoplasms; Melphalan; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Radiotherapy, High-Energy; Sacrum; Sphenoid Bone; Tibia; Vincristine

1975
[Mandibular plasmacytoma--primary lesion. Case report].
    Chirurgia maxillofacialis & plastica, 1970, Volume: 7, Issue:3

    Topics: Female; Fractures, Spontaneous; Humans; Mandibular Neoplasms; Melphalan; Middle Aged; Plasmacytoma

1970
THE MULTIFOCAL LYMPHOMA SYNDROME IN AFRICAN CHILDREN IN KENYA.
    The Journal of laryngology and otology, 1964, Volume: 78

    Topics: Adolescent; Alkylating Agents; Antineoplastic Agents; Aziridines; Black People; Burkitt Lymphoma; Child; Cyclophosphamide; Dactinomycin; Epidemiology; Humans; Kenya; Lymphoma; Mandibular Neoplasms; Maxillary Neoplasms; Melphalan; Neoplasms; Oncogenic Viruses

1964
[REGIONAL INTRA-ARTERIAL CHEMOTHERAPY OF MAXILLO-FACIAL CANCER].
    Voprosy onkologii, 1964, Volume: 10

    Topics: Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Facial Neoplasms; Humans; Lip Neoplasms; Mandibular Neoplasms; Maxillary Neoplasms; Melphalan; Mouth Neoplasms; Neoplasms; Parotid Neoplasms; Thiotepa; Tongue Neoplasms

1964
OSTEOGENIC SARCOMA OF THE MANDIBLE. REPORT OF CASE TREATED BY RADIATION AND CHEMOTHERAPY.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1964, Volume: 80

    Topics: Bone Neoplasms; Cobalt Isotopes; Dactinomycin; Drug Therapy; Humans; Mandible; Mandibular Neoplasms; Melphalan; Methotrexate; Neoplasms; Osteomyelitis; Osteosarcoma; Pathology; Radiography; Radium; Sarcoma

1964
ORAL MELPHALAN THERAPY IN ADVANCED MALIGNANT DISEASE.
    British journal of cancer, 1963, Volume: 17

    Topics: Adolescent; Child; Geriatrics; Head and Neck Neoplasms; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mandibular Neoplasms; Maxillary Neoplasms; Melanoma; Melphalan; Multiple Myeloma; Neoplasms; Orbital Neoplasms; Plasmacytoma; Sarcoma; Sarcoma, Kaposi

1963